News
-
Why flu can be fatalAfter an initial severe infection, patients may be at high risk of contracting secondary infections and developing fatal pneumonia.
-
Coming to the genetic rescue of our endangered marsupialsGenetic variation is essential for survival; it allows species to adapt and evolve so they can overcome disease and other environmental threats, and avoid the negative consequences of inbreeding.
-
Bio21 researchers reap rewards at ComBio2107 conferenceBio21 researchers from the Department of Biochemistry and Molecular Biology, including the Tilley, van Driel, McConville, Gleeson and Hinde labs made a good showing, presenting their work and collecting awards for their presentations.
-
Prof Eric Reynolds receives Prime Minster's Prize for Innovation19 October 2017
-
Media Release: University of Melbourne and Telix Pharmaceuticals Establish Cancer Translational Research PartnershipNovel technology discovered at University of Melbourne has the potential to transform the management of cancer
-
Bio21 NHMRC Grants fund Asthma, Antimicrobial Resistance and Dental Research.Congratulations to Kat Holt, Spencer Williams and Eric Reynolds upon receiving NHMRC funding.
-
Research Scientist for a week - By Elvis TranFor a week in June, I was no longer a student bound by books and constantly in a classroom setting. Instead, I had become a research scientist at Bio21, surrounded by million-dollar cutting-edge biotechnology.
-
President of Croatia, Her Excellency Ms Kolinda Grabar-Kitarovic visits Bio21Today an MOU was signed between the University of Melbourne and the University of Zagreb to facilitate research collaboration and PhD pathways.
-
Open House @ Bio21 - Saturday 29 & Sunday 30 July - Discover Science!Bio21 is open on Saturday & Sunday this weekend as part of the City of Melbourne's 'Open House' weekend.
-
Media Release: Discovery-driven research leads to breakthrough in understanding rare Sengers syndromeBio21 Researcher, Dr Diana Stojanovski, has unlocked important information that could lead to improved treatment of a rare and serious genetic condition, Senger's Syndrome.
